Assesment | Donker [23] | Jørgensen [12] | Moseholm [24] | Ingeman [27] | Stenman [10] | Dolly [21] | Møller [28] | Chapman [29] | ||
---|---|---|---|---|---|---|---|---|---|---|
1. Representativeness of the exposed cohort | + | + | + | + | + | + | + | + | + | + |
2. Selection of the non exposed cohort | + | + | + | + | + | + | + | + | + | + |
3. Ascertainment of exposure | + | + | + | + | + | + | + | + | + | + |
4. Demonstration that outcome of interest was not present at start of study | + | + | + | + | + | + | + | + | + | + |
5. Comparability of cohorts on the basis of the design or analysis | + | + | + | + | + | + | + | + | + | + |
6. Assessment of outcome | + | + | + | + | + | + | + | + | + | + |
7. Was follow-up long enough for outcomes to occur | + | + | + | + | + | + | + | + | + | + |
8. Adequacy of follow up of cohorts | + | + | + | + | + | + | + | + | + | + |
Stars summarized | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
Quality: Low/medium/high | High | High | High | High | High | High | High | High | High | High |
A. Socioeconomic characteristics | + | + | + | + | + | + | + | + | ||
B. Mental characteristics | – | + | + | + | + | + | + | + | ||
C. Physical characteristics | + | + | + | + | + | + | + | + | + | |
D. Patient Pathway | + | + | + | + | + | + | + | + | + | + |